Adenovirus early region 1A modulation of interferon antiviral activity.
Human adenovirus type 5 (Ad5) is a DNA virus which replicates as efficiently in human A549 cells treated with human interferon-alpha 2 (IFN) as in untreated cells. Vesicular stomatitis virus (VSV), on the other hand, is a negative-strand RNA virus which is very sensitive to the effects of IFN treatment in A549 cells. The IFN-mediated inhibition of VSV replication was not observed in cells coinfected with Ad5. Abrogation of IFN-mediated antiviral activity was maximal when Ad5 infection preceded VSV infection by at least 36 h, but did not require adenovirus DNA synthesis for manifestation. Coinfection experiments with VSV and deletion variants of adenovirus demonstrated that neither virus-associated RNA synthesis nor expression of adenovirus early regions E1B, E2A, E3, or E4 are required for abrogation of IFN-mediated inhibition of VSV replication. However, expression of early region E1A was essential, suggesting that E1A products can modulate, either directly or indirectly, IFN activity in adenovirus-infected cells.
D017456:Adenovirus Early Proteins; D000260:Adenoviruses, Human / Q000235:genetics* / Q000254:growth & development; D005786:Gene Expression Regulation; D005814:Genes, Viral; D007370:Interferon Type I / Q000037:antagonists & inhibitors*; D009856:Oncogene Proteins, Viral / Q000502:physiology*; D012367:RNA, Viral / Q000235:genetics; D014721:Vesicular stomatitis Indiana virus / Q000254:growth & development; D014764:Viral Proteins / Q000096:biosynthesis; D014779:Virus Replication / Q000187:drug effects*
D017456:Adenovirus Early Proteins; D007370:Interferon Type I; D009856:Oncogene Proteins, Viral; D012367:RNA, Viral; D014764:Viral Proteins